Description

Technical Parameters

Introduction

OIL

product-1400-1400

Products Description

### Systematic analysis of STADA brand high-quality oil Testosterone Cypionate 200

Testosterone Cypionate (testosterone cypionate) is a synthetic androgen preparation widely used in clinical practice, mainly used to treat male hypogonadism and other diseases related to testosterone deficiency. As a world-renowned pharmaceutical company, STADA's Testosterone Cypionate 200 (concentration 200 mg/mL) is known for its high purity, stability and bioavailability. This article will systematically analyze the core features of this product from multiple dimensions such as **chemical properties, dosage form design, pharmacological advantages, clinical application, and safety**.

---

#### 1. Chemical structure and physicochemical properties

1. **Molecular structure and chemical formula**

Testosterone Cypionate is an esterified derivative of testosterone (Testosterone), with the chemical name **17β-cyclopentyl propionate-4-androsten-3-one**, molecular formula **C₂₇H₄₀O₃**, and molecular weight 412.61 g/mol. Its structure significantly prolongs the half-life of the drug (about 8-12 days) and reduces the injection frequency by introducing the cyclopentyl propionate group (Cypionate ester) on the testosterone molecule.

2. **Solubility and stability**

- **Lipid solubility**: Due to esterification modification, the drug has high solubility in oily carriers (such as sesame oil and cottonseed oil). STADA uses refined carrier oil to ensure solution uniformity.

- **Stability**: It can maintain a shelf life of 24 months in a light-proof environment below 25°C, with a stable pH value of 6.0-7.5 to avoid local irritation.

- **Melting point**: About 101-104°C, in line with European Pharmacopoeia (EP) standards.

3. **Color and transparency**

STADA's oil is a **light yellow to amber transparent liquid**. The color difference comes from the type of carrier oil (such as sesame oil is yellowish) and the addition of antioxidants (such as vitamin E). There are no suspended particles or turbidity, which meets the standards for sterile injections.

---

#### 2. Dosage form design and production process

1. **High concentration and low volume formula**

Designed with a concentration of **200 mg/mL**, a single injection of 1 mL can provide sufficient testosterone, reduce the injection volume (traditional preparations are mostly 100-250 mg/mL), and reduce the risk of local pain and lipid deposition.

2. **Carrier oil selection**

STADA uses **hypoallergenic carrier oil** (such as fractionated coconut oil MCT), which significantly reduces the probability of allergic reactions compared to traditional cottonseed oil, while improving the drug sustained release effect.

3. **Aseptic filling and quality control**

- The production process complies with **GMP standards**, and terminal sterilization uses γ-ray irradiation to ensure sterility.

- Each batch of products passes **HPLC purity test** (≥99%), endotoxin (<0.1 EU/mg) and heavy metal residue (in compliance with ICH Q3D) tests.

---

#### 3. Pharmacological advantages

1. **Long-acting sustained release properties**

The hydrophobicity of cypionate allows the drug to form a "reservoir" after intramuscular injection, slowly hydrolyzing into free testosterone, maintaining a stable blood concentration of **7-14 days**, and avoiding frequent injections (compared to testosterone propionate, which requires 2-3 times a week).

2. **Optimized bioavailability**

- Carrier oil and esterification structure synergistically improve drug absorption rate, with bioavailability reaching **90%-95%**.

- Peak blood concentration (Cₘₐₓ) occurs **24-48 hours** after injection, and trough value (Cₘᵢₙ) is still higher than physiological level.

3. **Metabolism and excretion**

Mainly metabolized by liver CYP3A4 enzyme into active form (dihydrotestosterone, DHT) and inactive metabolites, 90% excreted through kidneys, 10% excreted through bile.

---

#### 4. Clinical application and indications

1. **Core indications**

- **Hypogonadism in men**: restore serum testosterone to the physiological range of 300-1000 ng/dL.

- **Delayed puberty**: promote the development of secondary sexual characteristics and bone growth.

- **Adjunctive treatment for wasting diseases**: such as AIDS-related muscle atrophy and cachexia in advanced cancer.

2. **Dosage regimen**

- **Standard treatment**: 200-400 mg/time, intramuscular injection once every 2-4 weeks, adjusted according to serum testosterone levels.

- **Special population**: Patients with liver and kidney dysfunction need to reduce the dose by 25%-50%.

3. **Efficacy data**

Clinical studies have shown that after 12 weeks of continuous treatment, the average muscle mass of patients increased by **5%-8%**, bone density increased by **2%-3%**, and sexual function scores (IIEF-5) improved by 40%-60%.

---

#### 5. Safety and adverse reaction management

1. **Common side effects**

- **Local reactions**: pain at the injection site (15%), redness and swelling (5%).

- **Systemic reactions**: acne (20%), polycythemia vera (10%), water and sodium retention (8%).

2. **Serious risk control**

- **Cardiovascular risk**: Regularly monitor blood lipids (LDL↑) and hematocrit (target <54%).

- **Hepatotoxicity**: Rare (<1%), it is recommended to check liver function every 6 months.

3. **Contraindications**

Prohibited for patients with prostate cancer, breast cancer, and severe heart failure.

---

#### 6. Core competitiveness of STADA brand

1. **Production process advantages**

- Adopt **Nanofiltration technology** to remove impurities and reduce immunogenicity.

- Fully automatic nitrogen filling to prevent oxidative degradation.

2. **Global compliance**

Certified by **FDA, EMA, NMPA**, in compliance with USP/EP dual standards, exported to more than 50 countries.

3. **Patient support system**

Provide customized syringes (ultra-fine 25G needles), medication tracking APP and 24-hour pharmacist consultation.

---

#### 7. Conclusion

STADA's Testosterone Cypionate 200 has become the preferred option for testosterone replacement therapy (TRT) through **precise esterification design, high-purity raw materials, strict quality control** and **humanized dosage form**. Its long-term efficacy, safety and brand trust provide a reliable hormone management tool for patients around the world. However, it needs to be used under the guidance of a specialist to balance efficacy and risks and achieve individualized treatment goals.